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Sphingolipid de novo synthesis is initiated by the 
condensation of an activated fatty acid (normally pal-
mitoyl-CoA) and l-serine to form SA. This reaction is 
catalyzed by SPT. In HSAN1, the SPT shows a shift in 
substrate specificity to alanine, which results in the for-
mation of an atypical class of dSLs. For SA and doxSA 
(1-deoxysphinganine), the number of hydroxyl groups 
is indicated by m (mono-) and d (di-), followed by the 
number of carbons; the second number indicates the 
double bonds.
Figure 2
Kinetic characterization of WT and mutant SPT. (A) Suppression of doxSA production in SPTLC1 WT HEK cells by increasing l-serine medium 
concentrations in the background of varying l-alanine concentrations. (B) Suppression of doxSA generation in SPTLC1 WT and HSAN1 mutant–
expressing HEK293 cells at increasing l-serine medium concentrations (constant background of 2 mM l-alanine).
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Effects of supplementation on l-serine/l-alanine concentrations. 
C133W transgenic mice were fed diets with 10% l-serine, 10% l-ala-
nine, or were left untreated. (A) Plasma levels after 3 days on diet 
demonstrated a significant increase in the ratio of l-serine to l-alanine 
in plasma of l-serine–fed mice relative to the untreated group. In con-
trast, mice fed l-alanine had a decrease in amino acid ratio. (B) Sci-
atic nerve showed a similar change in the l-serine/l-alanine ratio after 
9–12 months of supplementation. (C) Liver did not show significant 
differences between treatment groups. *P < 0.05; **P < 0.01. Error 
bars represent SEM.
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Effect of supplementation on 
peripheral nerve
On  l-serine, C133W mice  showed 
no  difference  in  axon  density  of 



































Effects of supplementation on plasma dSL levels in C133W transgenic mice. C133W transgenic mice 
were fed either 10% l-serine–supplemented or 10% l-alanine–supplemented diet. Plasma samples 
were drawn every third day. Lipids were extracted and subjected to acid, and base hydrolysis and 
free sphingoid bases were quantified by liquid chromatography–mass spectrometry. (A) SA levels did 
not differ as a consequence of supplementation. (B) l-serine diet induced a significant reduction in 
doxSA plasma levels within the first 3 days. l-alanine caused an initial increase in doxSA levels and 
subsequent fluctuations. (C) Dietary supplementation did not significantly affect SO plasma levels. (D) 
DoxSO levels decreased after l-serine supplementation, while increasing in response to l-alanine.
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Effects of supplementation on behavior in C133W transgenic mice. (A) Experimental design. Red bar, l-alanine supplementation; blue bars, 
l-serine supplementation; arrows, time of sensory testing. (B) In l-alanine–supplemented mice, a trend toward worse motor performance was 
seen on rotarod. (C) Mechanical sensitivity was significantly worse compared with untreated age-matched C133W transgenic and WT mice. (D) 
In contrast, l-serine had no effect on the motor performance of 15-month-old transgenic mice, but (E) a beneficial effect on mechanical sensitiv-
ity was seen. (F) Long-term l-serine treatment improved motor performance compared with untreated age-matched C133W transgenic and WT 
mice. (G) Mechanical sensitivity showed a trend toward improvement relative to untreated C133W transgenic mice. Data (mean ± SEM) show 
percentage of age-matched, control diet–fed WT value. **P < 0.05 vs. untreated C133W transgenic mice.
Figure 6
Effect of 9–12 months’ dietary supplementation on 
tissue dSL levels in C133W transgenic mice. (A) 
l-serine caused a significant increase of SA in liver. 
(B) Compared with untreated controls, doxSA lev-
els decreased slightly with l-serine treatment and 
increased with l-alanine treatment in C133W trans-
genic mice. (C) No significant trend was noted for 
SO tissue levels. (D) DoxSO was found in liver and 
sciatic nerve, but showed no apparent dependence 
upon dietary supplementation. (Because doxSO was 
not detected in tissue of WT mice on a control diet, 
mean values are expressed in pmol per μg protein). 
Error bars represent SEM. **P < 0.05.
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Effects of supplementation on sciatic nerve morphology. C133W transgenic mice were fed diets with 10% l-serine or 10% l-alanine. (A) 
Experimental design. Red bar, l-alanine supplementation; blue bar, l-serine supplementation; end of bar denotes time of sacrifice. (B) Quanti-
fication of unmyelinated axons revealed rescue of large-caliber axons in young l-serine–treated mice (blue) relative to age-matched untreated 
C133W transgenic animals (dotted black line; data from ref. 13) and young l-alanine–treated mice (red). Arrow indicates relative decrease in 
large-caliber axons. (C) EM images of unmyelinated axons from l-serine– and l-alanine–fed mice. Scale bars: 500 nm. (D) Myelinated axons 
in l-serine–treated animals demonstrated a similar trend of preservation of large axons. Dotted black line represent age-matched untreated 
C133W transgenic animals (data from ref. 13). Arrow indicates relative decrease in large-caliber axons. (E) EM images of myelinated axons from 
l-serine– and l-alanine–fed mice. Scale bars: 10 μm. (F) Change in myelination patterns after supplementation, assessed by g ratios. Dotted 
black line represents old untreated C133W transgenic animals (data from ref. 13). Error bars represent SEM.
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Effects of supplementation on the repro-
ductive system of C133W transgenic 
mice. (A) Experimental design. Red bar, 
l-alanine supplementation; blue bar, 
l-serine supplementation; arrows, time 
of reproductive analysis. (B–D) Young 
C133W transgenic mice fed l-alanine–
supplemented diet did not differ from 
C133W transgenic or WT control ani-
mals on measures of testes weight (B), 
sperm count (C), or sperm motility (D). 
(E–G) l-serine–treated C133W trans-
genic mice were found to have increased 
sperm count (F), but no differences in 
testes weight (E) or sperm motility (G). 
Data (mean ± SEM) show percentage of 
age-matched, control diet–fed WT value. 
**P < 0.05.
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Effects of l-serine supplementation on human 
HSAN1 patients. (A) Design of the pilot study. 
Solid line, l-serine supplementation period; gray 
line, washout period. Plasma levels of SA (B) 
and SO (D) increased substantially during l-ser-
ine treatment. In contrast, doxSA (C) and doxSO 
(E) decreased in HSAN1 patients, reached a 
nadir within 4–6 weeks, and showed greater sup-
pression at the higher dose. During the washout 
phase, dSL levels began to rise. Vertical lines at 
10 weeks denote the beginning of washout.
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